In addition to genetic alterations of PTEN in human cancers, various post-translational modifications (PTMs) of PTEN have been actively investigated, including phosphorylation, ubiquitination, acetylation and oxidation; these PTMs control the ability of PTEN to inhibit PI3K/AKT signalling7, 12, 13, 14. Here, AKT1 is linked to cancer.